ADHD in the DSM-5-TR: What has changed and what has not

Athanasios Koutsoklenis; Juho Honkasilta

doi:10.3389/fpsyt.2022.1064141

ADHD in the DSM-5-TR: What has changed and what has not

Athanasios Koutsoklenis, Juho Honkasilta

Research output: Contribution to journal › Article › Scientific › peer-review

Abstract

In this article, we critically review the changes made to the DSM-5 Text Revision published in 2022 regarding the diagnostic entity of Attention Deficit/Hyperactivity Disorder (ADHD). We structure our critique around three points. The first discusses the acknowledgment of ADHD as a neurodevelopmental disorder. The second examines the definition of ADHD provided in the updated edition of the manual. The third scrutinizes the changes in the diagnostic criteria for ADHD and assesses whether these changes make the diagnosis more accurate. We conclude that DSM's latest edition does not escape the logical and scientific pitfalls of its predecessor. DSM-5-TR keeps the faith in the neo-Kraepelinian paradigm by explicitly and implicitly cultivating the essentialist medical scientific metaphor of disorder, creating the illusion that it represents scientific progress that validates ADHD as a neurodevelopmental disorder.

Original language	English
Article number	1064141
Journal	Frontiers in psychiatry
Volume	13
Number of pages	6
ISSN	1664-0640
DOIs	https://doi.org/10.3389/fpsyt.2022.1064141
Publication status	Published - 10 Jan 2023
MoE publication type	A1 Journal article-refereed

Fields of Science

Adhd
American Psychiatric Association
Diagnosis
Diagnostic manual
Dsm-5-tr
Revisions
3124 Neurology and psychiatry

Access to Document

10.3389/fpsyt.2022.1064141

fpsyt-13-1064141Final published version, 266 KBLicence: CC BY

Cite this

@article{525c8c31e6e0497f8e388dfbf1c04a2a,

title = "ADHD in the DSM-5-TR: What has changed and what has not",

abstract = "In this article, we critically review the changes made to the DSM-5 Text Revision published in 2022 regarding the diagnostic entity of Attention Deficit/Hyperactivity Disorder (ADHD). We structure our critique around three points. The first discusses the acknowledgment of ADHD as a neurodevelopmental disorder. The second examines the definition of ADHD provided in the updated edition of the manual. The third scrutinizes the changes in the diagnostic criteria for ADHD and assesses whether these changes make the diagnosis more accurate. We conclude that DSM's latest edition does not escape the logical and scientific pitfalls of its predecessor. DSM-5-TR keeps the faith in the neo-Kraepelinian paradigm by explicitly and implicitly cultivating the essentialist medical scientific metaphor of disorder, creating the illusion that it represents scientific progress that validates ADHD as a neurodevelopmental disorder.",

keywords = "Adhd, American Psychiatric Association, Diagnosis, Diagnostic manual, Dsm-5-tr, Revisions, 3124 Neurology and psychiatry",

author = "Athanasios Koutsoklenis and Juho Honkasilta",

year = "2023",

month = jan,

day = "10",

doi = "10.3389/fpsyt.2022.1064141",

language = "English",

volume = "13",

journal = "Frontiers in psychiatry",

issn = "1664-0640",

publisher = "Frontiers Media",

}

TY - JOUR

T1 - ADHD in the DSM-5-TR: What has changed and what has not

AU - Koutsoklenis, Athanasios

AU - Honkasilta, Juho

PY - 2023/1/10

Y1 - 2023/1/10

N2 - In this article, we critically review the changes made to the DSM-5 Text Revision published in 2022 regarding the diagnostic entity of Attention Deficit/Hyperactivity Disorder (ADHD). We structure our critique around three points. The first discusses the acknowledgment of ADHD as a neurodevelopmental disorder. The second examines the definition of ADHD provided in the updated edition of the manual. The third scrutinizes the changes in the diagnostic criteria for ADHD and assesses whether these changes make the diagnosis more accurate. We conclude that DSM's latest edition does not escape the logical and scientific pitfalls of its predecessor. DSM-5-TR keeps the faith in the neo-Kraepelinian paradigm by explicitly and implicitly cultivating the essentialist medical scientific metaphor of disorder, creating the illusion that it represents scientific progress that validates ADHD as a neurodevelopmental disorder.

AB - In this article, we critically review the changes made to the DSM-5 Text Revision published in 2022 regarding the diagnostic entity of Attention Deficit/Hyperactivity Disorder (ADHD). We structure our critique around three points. The first discusses the acknowledgment of ADHD as a neurodevelopmental disorder. The second examines the definition of ADHD provided in the updated edition of the manual. The third scrutinizes the changes in the diagnostic criteria for ADHD and assesses whether these changes make the diagnosis more accurate. We conclude that DSM's latest edition does not escape the logical and scientific pitfalls of its predecessor. DSM-5-TR keeps the faith in the neo-Kraepelinian paradigm by explicitly and implicitly cultivating the essentialist medical scientific metaphor of disorder, creating the illusion that it represents scientific progress that validates ADHD as a neurodevelopmental disorder.

KW - Adhd

KW - American Psychiatric Association

KW - Diagnosis

KW - Diagnostic manual

KW - Dsm-5-tr

KW - Revisions

KW - 3124 Neurology and psychiatry

U2 - 10.3389/fpsyt.2022.1064141

DO - 10.3389/fpsyt.2022.1064141

M3 - Article

SN - 1664-0640

VL - 13

JO - Frontiers in psychiatry

JF - Frontiers in psychiatry

M1 - 1064141

ER -